Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) is set to make a significant presence at Citi’s 2025 Global Healthcare Conference on December 3, 2025. This event will feature key insights from ...
Inflation should have a minimal impact on these companies' financial results. And they also boast excellent growth prospects.
Vertex Pharmaceuticals Incorporated today announced management participation in Citi's 2025 Global Healthcare Conference. Charlie Wagner, Chief Operating and Financial Officer, and David Altshuler, ...
Barchart on MSN
This Leading Gene-Editing Stock Could Be Going Private. Should You Buy Its Shares First?
The global cell therapy market was valued at $5.88 billion in 2024 and is on track to hit $44.39 billion by 2034, expanding ...
US stocks trimmed earlier gains to finish moderately higher on Wednesday, partially bouncing back after a four-day losing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback